TheWell Bioscience

TheWell Bioscience Inc. is a company focused on accelerating the process of drug discovery and personalized medicine through the development of advanced biomaterials and 3D cell culture models. Their flagship product, VitroGel, is a ready-to-use and tunable hydrogel that enables the creation of physiologically relevant multicellular tissue or disease models for regenerative medicine and drug discovery applications.

To address the limitations of existing bioinks for 3D bioprinting, TheWell Bioscience introduced VitroINK, a novel bioink with superior mechanical strength and printability compared to traditional hydrogels like GelMA. VitroINK is a ready-to-use, room-temperature bioink that offers greater visibility after printing and can incorporate multiple bio-functional ligands for different applications.

The company's bioinks leverage unique shear-thinning and rapid recovery mechanical properties, allowing printed structures to maintain their shape without the need for UV curing or other specialized techniques. Simply adding cell culture medium after printing stabilizes the structure and supports cell growth, making VitroINK a powerful tool for advancing 3D bioprinting in research and pharmaceutical applications.

TheWell Bioscience's advanced biomaterials can also be used as injectable carriers to improve cell therapy, drug screening, tissue engineering, preclinical studies, and basic cell biology research. By providing more accurate representations of the natural cellular environment, the company's 3D cell culture models enable more realistic biochemical and physiological responses compared to traditional 2D cell culture methods.